Approvals/CIMA-AEMPS/SOLIFENACINA/TAMSULOSINA PENSA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA EFG

Approved

STANDARD

SOLIFENACINA/TAMSULOSINA PENSA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA EFG

Towa Pharmaceutical S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 4dcf93e1a988ff00
Drug Cima Aemps Name: SOLIFENACINA/TAMSULOSINA PENSA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA EFG
Register Number: 88683
Holder Company Name: Towa Pharmaceutical S.A.
Marketing Company Name: Towa Pharmaceutical S.A.
Authorization Date: 2023-02-22
Dosage Form: COMPRIMIDO DE LIBERACIÓN MODIFICADA
Dose: 6 mg/0,4 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Towa Pharmaceutical S.A.

TAMSULOSINA HIDROCLORURO

0,4 mg

SOLIFENACINA SUCCINATO

6 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 22, 2023

Approval ID

4dcf93e1a988ff00

Type

Standard